Costo de la polifarmacia en el paciente con diabetes mellitus tipo 2

Background: Polypharmacy or the concomitant use of three or more medications, may increase the complexity of health care and its costs. Aim: To determine the costs of polypharmacy in patients with Type 2 Diabetes Mellitus in a Mexican population sample. Patients and Methods: Analysis of health care...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	García A,Luz María, Villarreal R,Enrique, Galicia R,Liliana, Martínez G,Lidia, Vargas D,Emma Rosa
Lenguaje:	Spanish / Castilian
Publicado:	Sociedad Médica de Santiago 2015
Materias:	Diabetes complications Diabetes Mellitus Type 2 Health care costs Health economics and organizations Polypharmacy
Acceso en línea:	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872015000500008
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:scielo:S0034-98872015000500008
record_format	dspace
spelling	oai:scielo:S0034-988720150005000082018-10-31Costo de la polifarmacia en el paciente con diabetes mellitus tipo 2García A,Luz MaríaVillarreal R,EnriqueGalicia R,LilianaMartínez G,LidiaVargas D,Emma Rosa Diabetes complications Diabetes Mellitus Type 2 Health care costs Health economics and organizations Polypharmacy Background: Polypharmacy or the concomitant use of three or more medications, may increase the complexity of health care and its costs. Aim: To determine the costs of polypharmacy in patients with Type 2 Diabetes Mellitus in a Mexican population sample. Patients and Methods: Analysis of health care costs in 257 patients with Type 2 Diabetes Mellitus from two family care facilities, who had at least five consultations during one year. The cost of professional care by family physicians, pharmacological care and medications were considered to calculate the total expenses. The price of medications and the number of units consumed in one year were used to determine pharmacological expenses. Medications were grouped to determine costs derived from complications and concomitant diseases. Costs were calculated in US dollars (USD). Results: The mean cost derived from family physician fees was USD 82.32 and from pharmacy fees USD 29.37. The mean cost of medications for diabetes treatment was USD 33.31, for the management of complications USD 13.9 and for management of concomitant diseases USD 23.7, rendering a total cost of USD 70.92. Thus, the total annual care cost of a diabetic patient was USD 182.61. Conclusions: Medications represent less than 50% of total expenses of diabetic patients with polypharmacy.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.143 n.5 20152015-05-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872015000500008es10.4067/S0034-98872015000500008
institution	Scielo Chile
collection	Scielo Chile
language	Spanish / Castilian
topic	Diabetes complications Diabetes Mellitus Type 2 Health care costs Health economics and organizations Polypharmacy
spellingShingle	Diabetes complications Diabetes Mellitus Type 2 Health care costs Health economics and organizations Polypharmacy García A,Luz María Villarreal R,Enrique Galicia R,Liliana Martínez G,Lidia Vargas D,Emma Rosa Costo de la polifarmacia en el paciente con diabetes mellitus tipo 2
description	Background: Polypharmacy or the concomitant use of three or more medications, may increase the complexity of health care and its costs. Aim: To determine the costs of polypharmacy in patients with Type 2 Diabetes Mellitus in a Mexican population sample. Patients and Methods: Analysis of health care costs in 257 patients with Type 2 Diabetes Mellitus from two family care facilities, who had at least five consultations during one year. The cost of professional care by family physicians, pharmacological care and medications were considered to calculate the total expenses. The price of medications and the number of units consumed in one year were used to determine pharmacological expenses. Medications were grouped to determine costs derived from complications and concomitant diseases. Costs were calculated in US dollars (USD). Results: The mean cost derived from family physician fees was USD 82.32 and from pharmacy fees USD 29.37. The mean cost of medications for diabetes treatment was USD 33.31, for the management of complications USD 13.9 and for management of concomitant diseases USD 23.7, rendering a total cost of USD 70.92. Thus, the total annual care cost of a diabetic patient was USD 182.61. Conclusions: Medications represent less than 50% of total expenses of diabetic patients with polypharmacy.
author	García A,Luz María Villarreal R,Enrique Galicia R,Liliana Martínez G,Lidia Vargas D,Emma Rosa
author_facet	García A,Luz María Villarreal R,Enrique Galicia R,Liliana Martínez G,Lidia Vargas D,Emma Rosa
author_sort	García A,Luz María
title	Costo de la polifarmacia en el paciente con diabetes mellitus tipo 2
title_short	Costo de la polifarmacia en el paciente con diabetes mellitus tipo 2
title_full	Costo de la polifarmacia en el paciente con diabetes mellitus tipo 2
title_fullStr	Costo de la polifarmacia en el paciente con diabetes mellitus tipo 2
title_full_unstemmed	Costo de la polifarmacia en el paciente con diabetes mellitus tipo 2
title_sort	costo de la polifarmacia en el paciente con diabetes mellitus tipo 2
publisher	Sociedad Médica de Santiago
publishDate	2015
url	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872015000500008
work_keys_str_mv	AT garciaaluzmaria costodelapolifarmaciaenelpacientecondiabetesmellitustipo2 AT villarrealrenrique costodelapolifarmaciaenelpacientecondiabetesmellitustipo2 AT galiciarliliana costodelapolifarmaciaenelpacientecondiabetesmellitustipo2 AT martinezglidia costodelapolifarmaciaenelpacientecondiabetesmellitustipo2 AT vargasdemmarosa costodelapolifarmaciaenelpacientecondiabetesmellitustipo2
_version_	1718436821541584896

Costo de la polifarmacia en el paciente con diabetes mellitus tipo 2

Ejemplares similares